A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema（DME）
Clinical trial NCT06908876 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06908876
- Sponsor
- Innovent Biologics Technology Limited (Shanghai R&D Center)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-24
- Primary completion
- 2026-12-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.